US Stock MarketDetailed Quotes

NRX Pharmaceuticals (NRXP)

Watchlist
  • 2.340
  • +0.080+3.54%
Close Jan 22 16:00 ET
  • 2.270
  • -0.070-2.99%
Pre 07:03 ET
69.28MMarket Cap-1.01P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NRX Pharmaceuticals (NRXP) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
242K
0
0
0
0
0
0
0
0
0
Operating revenue
--242K
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
97K
Gross profit
145K
Operating expense
37.95%4.17M
-47.09%3.73M
-37.53%3.75M
-32.93%18.5M
-41.48%2.43M
-47.97%3.02M
-11.19%7.05M
-36.43%6M
-37.78%27.59M
-57.97%4.16M
Selling and administrative expenses
16.56%2.81M
-35.40%2.74M
-30.75%2.94M
-5.00%13.51M
39.00%2.6M
-3.41%2.41M
4.45%4.25M
-26.53%4.25M
-47.94%14.22M
-65.54%1.87M
-General and administrative expense
----
-35.40%2.74M
-30.75%2.94M
-5.00%13.51M
38.78%2.6M
-3.33%2.41M
4.45%4.25M
-26.53%4.25M
-47.94%14.22M
-65.54%1.87M
Research and development costs
133.88%1.43M
-64.80%987K
-54.00%804K
-53.64%6.2M
-59.12%1.04M
-81.56%611K
-27.60%2.8M
-52.11%1.75M
-21.47%13.37M
-43.13%2.53M
Depreciation amortization depletion
1,200.00%26K
----
----
----
----
--2K
----
----
----
----
-Depreciation and amortization
1,200.00%26K
----
----
----
----
--2K
----
----
----
----
Other operating expenses
---94K
----
----
-580.80%-1.2M
----
----
----
----
--250K
--0
Operating profit
-33.16%-4.02M
47.09%-3.73M
37.53%-3.75M
32.93%-18.5M
41.48%-2.43M
47.97%-3.02M
11.19%-7.05M
36.43%-6M
37.78%-27.59M
57.97%-4.16M
Net non-operating interest income expense
-66.67%2K
-71.43%2K
101.97%4K
-149.73%-186K
166.67%4K
-92.41%6K
-95.17%7K
-230.13%-203K
50.20%374K
-104.51%-6K
Non-operating interest income
-66.67%2K
-71.43%2K
-85.19%4K
-91.09%44K
-94.59%4K
-94.96%6K
-95.17%7K
-82.69%27K
98.39%494K
-43.08%74K
Non-operating interest expense
--0
--0
--0
91.67%230K
--0
--0
--0
--230K
--120K
2,766.67%80K
Other net income (expense)
-234.10%-1.87M
-1,522.13%-13.85M
-440.98%-1.77M
-119.20%-6.44M
-3,811.76%-6.65M
518.32%1.39M
7.58%-854K
81.42%-327K
-167.80%-2.94M
65.02%-170K
Gain on sale of security
146.06%406K
-35,733.33%-6.41M
18,088.89%1.62M
-8,385.00%-1.66M
-26,057.14%-1.83M
534.62%165K
263.64%18K
-175.00%-9K
-92.16%20K
-136.84%-7K
Special income (charges)
-507.87%-772K
--0
---100K
----
----
---127K
--0
--0
-105.46%-250K
---250K
-Less:Other special charges
507.87%772K
----
--100K
----
----
--127K
----
----
--250K
----
Other non- operating income (expenses)
-210.85%-1.5M
-753.10%-7.44M
-933.96%-3.29M
-76.62%-4.78M
-5,785.06%-4.95M
477.44%1.36M
-31.52%-872K
82.05%-318K
-436.04%-2.71M
--87K
Income before tax
-262.91%-5.89M
-122.63%-17.58M
15.56%-5.51M
16.66%-25.13M
-109.56%-9.08M
73.23%-1.62M
9.41%-7.9M
40.86%-6.53M
24.16%-30.15M
57.70%-4.33M
Income tax
Net income
-262.91%-5.89M
-122.63%-17.58M
15.56%-5.51M
16.66%-25.13M
-109.56%-9.08M
73.23%-1.62M
9.41%-7.9M
40.86%-6.53M
24.16%-30.15M
57.70%-4.33M
Net income continuous Operations
-262.91%-5.89M
-122.63%-17.58M
15.56%-5.51M
16.66%-25.13M
-109.56%-9.08M
73.23%-1.62M
9.41%-7.9M
40.86%-6.53M
24.16%-30.15M
57.70%-4.33M
Minority interest income
Net income attributable to the parent company
-262.91%-5.89M
-122.63%-17.58M
15.56%-5.51M
16.66%-25.13M
-109.56%-9.08M
73.23%-1.62M
9.41%-7.9M
40.86%-6.53M
24.16%-30.15M
57.70%-4.33M
Preferred stock dividends
Other preferred stock dividends
0
9K
Net income attributable to common stockholders
-262.91%-5.89M
-122.63%-17.58M
15.56%-5.51M
16.69%-25.13M
-109.12%-9.08M
73.23%-1.62M
9.41%-7.9M
40.86%-6.53M
24.14%-30.16M
57.61%-4.34M
Basic earnings per share
-80.00%-0.27
-30.67%-0.98
54.05%-0.34
40.70%-2.36
-54.00%-0.77
79.73%-0.15
38.02%-0.75
95.54%-0.74
33.67%-3.98
66.67%-0.5
Diluted earnings per share
-80.00%-0.27
-30.67%-0.98
54.05%-0.34
40.70%-2.36
-54.00%-0.77
79.73%-0.15
38.02%-0.75
95.54%-0.74
33.67%-3.98
66.67%-0.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 242K000000000
Operating revenue --242K--0--0--0--0--0--0--0--0--0
Cost of revenue 97K
Gross profit 145K
Operating expense 37.95%4.17M-47.09%3.73M-37.53%3.75M-32.93%18.5M-41.48%2.43M-47.97%3.02M-11.19%7.05M-36.43%6M-37.78%27.59M-57.97%4.16M
Selling and administrative expenses 16.56%2.81M-35.40%2.74M-30.75%2.94M-5.00%13.51M39.00%2.6M-3.41%2.41M4.45%4.25M-26.53%4.25M-47.94%14.22M-65.54%1.87M
-General and administrative expense -----35.40%2.74M-30.75%2.94M-5.00%13.51M38.78%2.6M-3.33%2.41M4.45%4.25M-26.53%4.25M-47.94%14.22M-65.54%1.87M
Research and development costs 133.88%1.43M-64.80%987K-54.00%804K-53.64%6.2M-59.12%1.04M-81.56%611K-27.60%2.8M-52.11%1.75M-21.47%13.37M-43.13%2.53M
Depreciation amortization depletion 1,200.00%26K------------------2K----------------
-Depreciation and amortization 1,200.00%26K------------------2K----------------
Other operating expenses ---94K---------580.80%-1.2M------------------250K--0
Operating profit -33.16%-4.02M47.09%-3.73M37.53%-3.75M32.93%-18.5M41.48%-2.43M47.97%-3.02M11.19%-7.05M36.43%-6M37.78%-27.59M57.97%-4.16M
Net non-operating interest income expense -66.67%2K-71.43%2K101.97%4K-149.73%-186K166.67%4K-92.41%6K-95.17%7K-230.13%-203K50.20%374K-104.51%-6K
Non-operating interest income -66.67%2K-71.43%2K-85.19%4K-91.09%44K-94.59%4K-94.96%6K-95.17%7K-82.69%27K98.39%494K-43.08%74K
Non-operating interest expense --0--0--091.67%230K--0--0--0--230K--120K2,766.67%80K
Other net income (expense) -234.10%-1.87M-1,522.13%-13.85M-440.98%-1.77M-119.20%-6.44M-3,811.76%-6.65M518.32%1.39M7.58%-854K81.42%-327K-167.80%-2.94M65.02%-170K
Gain on sale of security 146.06%406K-35,733.33%-6.41M18,088.89%1.62M-8,385.00%-1.66M-26,057.14%-1.83M534.62%165K263.64%18K-175.00%-9K-92.16%20K-136.84%-7K
Special income (charges) -507.87%-772K--0---100K-----------127K--0--0-105.46%-250K---250K
-Less:Other special charges 507.87%772K------100K----------127K----------250K----
Other non- operating income (expenses) -210.85%-1.5M-753.10%-7.44M-933.96%-3.29M-76.62%-4.78M-5,785.06%-4.95M477.44%1.36M-31.52%-872K82.05%-318K-436.04%-2.71M--87K
Income before tax -262.91%-5.89M-122.63%-17.58M15.56%-5.51M16.66%-25.13M-109.56%-9.08M73.23%-1.62M9.41%-7.9M40.86%-6.53M24.16%-30.15M57.70%-4.33M
Income tax
Net income -262.91%-5.89M-122.63%-17.58M15.56%-5.51M16.66%-25.13M-109.56%-9.08M73.23%-1.62M9.41%-7.9M40.86%-6.53M24.16%-30.15M57.70%-4.33M
Net income continuous Operations -262.91%-5.89M-122.63%-17.58M15.56%-5.51M16.66%-25.13M-109.56%-9.08M73.23%-1.62M9.41%-7.9M40.86%-6.53M24.16%-30.15M57.70%-4.33M
Minority interest income
Net income attributable to the parent company -262.91%-5.89M-122.63%-17.58M15.56%-5.51M16.66%-25.13M-109.56%-9.08M73.23%-1.62M9.41%-7.9M40.86%-6.53M24.16%-30.15M57.70%-4.33M
Preferred stock dividends
Other preferred stock dividends 09K
Net income attributable to common stockholders -262.91%-5.89M-122.63%-17.58M15.56%-5.51M16.69%-25.13M-109.12%-9.08M73.23%-1.62M9.41%-7.9M40.86%-6.53M24.14%-30.16M57.61%-4.34M
Basic earnings per share -80.00%-0.27-30.67%-0.9854.05%-0.3440.70%-2.36-54.00%-0.7779.73%-0.1538.02%-0.7595.54%-0.7433.67%-3.9866.67%-0.5
Diluted earnings per share -80.00%-0.27-30.67%-0.9854.05%-0.3440.70%-2.36-54.00%-0.7779.73%-0.1538.02%-0.7595.54%-0.7433.67%-3.9866.67%-0.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -